Masimo (Nasdaq: MASI) + shareholders voted to oust two members of the device developer’s board after a heated battle by activist investor Politan Capital Management.
Masimo has yet to release official results, but acknowledged defeat today in a statement to MassDevice.
“We are disappointed to have lost the valuable contributions of two very qualified and capable board members,” Masimo spokesperson Evan Lamb emailed. “We are committed to continuing to innovate revolutionary products for patients and consumers worldwide.”
Politan Managing Partner and Chief Investment Officer Quentin Koffey and former Johnson & Johnson MedTech executive Michelle Brennan will join the Masimo board.Politan Managing Partner and Chief Investment Officer Quentin Koffey [Photo courtesy of Politan Capital Management]“Michelle and I would like to thank our fellow shareholders for their support and en…